Aier Eye Hospital Group Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
35 / 242
Position in country
714 / 7387
Return on Assets, %
12.7
3.5
Net income margin, %
18.8
6.3
EBITDA margin, %
32.6
18
Debt to Equity, %
25
51.4
Intangible assets and goodwill, %
22.4
2.7
Revenue CAGR 3Y, %
17.2
11.3
Total Equity change 1Y, %
5.9
1.4
Revenue Y, % chg
12.8
7.1
P/E
33.7
23.4
P/BV
6
2.1
P/S
6
2
EV/S
5.9
2.5
EV/EBITDA
23
11.9
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
97.6
18.4
Forward P/E
25.7
23.9
Dividend Yield, %
0.6
1.8
Forward Dividend Yield, %
0.1
0.2
Expected dividend per share
0
0
Payout Ratio, %
24.3
23.7
Dividend Ex Date
2023-06-08
Competitors
Ranks
-
Aier Eye Hospital Group Co Ltd
00%
-
Huaxia Eye Hospital Group Co Ltd
00%
-
Sanbo Hospital Management Group Ltd
00%
-
Chengdu Bright Eye Hospital Co Ltd
00%
-
Hygeia Healthcare Holdings Co Ltd
00%
-
HCA Healthcare Inc
00%
-
Dr Sulaiman Al Habib Medical Services Group Company SJSC
00%
-
XiAn International Medical Investment Co Ltd
00%
-
New Journey Health Technology Group Co Ltd
00%
-
Concord Healthcare Group Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Providers & Services
Sub-sector
Health Care
Capitalization (millions of $)
15853.9
Ticker
300015.SZ
ISIN
CNE100000GR6
IPO date
2009-10-30
Availability on Russian exchanges
No
Reporting for
2023-08-24
Date fact. publication of reports
2023-06-30
Company Description
Aier Eye Hospital Group Co.,Ltd. is a China-based ophthalmic medical institution. The Company is mainly engaged in ophthalmic diseases treatment, surgical services and medical optometry. The Company mainly provides corneal refractive surgery, cataract operation, anterior segment operation, posterior segment operation and optometry services. The Company mainly operates its business in domestic market, with Central China as its main market.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: